Ductal Carcinoma in Situ [DCIS] / AHRQ

New AHRQ Evidence Report on Ductal Carcinoma in Situ Is Available

AHRQ has released a new evidence report that found the incidence of ductal carcinoma in situ—the most common type of breast cancer—has continued to increase in the post-mammography era. Researchers led by Beth A. Virnig, Ph.D., M.P.H., identified the need to better understand whether it is possible to modify current imaging technologies or screening guidelines to more effectively identify lesions that are unlikely to become clinically problematic, as well as tumors that are likely to contain some invasive component. While evidence supports treating ductal carcinoma in situ, ongoing trials are exploring the best clinical strategy for treating ductal carcinoma in situ. The report, Diagnosis and Management of Ductal Carcinoma in Situ, was conducted by AHRQ’s Minnesota University Evidence-based Practice Center and was requested and funded by the NIH’s Office of Medical Applications of Research, for a State-of-the-Science Conference on the topic on September 22-24, 2009. Select to access the report. (PDF File), (PDF Help)

abrir aquí para acceder al documento AHRQ en versión PDF de 5.61MB y 549 PÁGINAS:
http://www.ahrq.gov/downloads/pub/evidence/pdf/dcis/dcis.pdf